Stocksigma LogoStocksigma Logo

BSE Approves Trading of Dharti Proteins Post-Resolution Restructured Equity Shares

BSE has granted trading approval for 5,00,000 equity shares (face value Rs. 10 each) of Dharti Proteins Ltd, effective 8th Oct'26 in the XT group under

BSE Approves Trading of Dharti Proteins Post-Resolution Restructured Equity Shares

Devika Proteins Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 3:57 pm

BSE Approves Trading of Dharti Proteins Post-Resolution Restructured Equity Shares BSE has granted trading approval for 5,00,000 equity shares (face value Rs. 10 each) of Dharti Proteins Ltd, effective 8th Oct'26 in the XT group under Trade-to-Trade segment. Pursuant to the NCLT-approved resolution plan dated 18th Nov'25, paid-up capital was restructured from Rs. 10.28 cr (1.03 cr shares) to Rs. 50.00 lakh (5,00,000 shares). The allotment comprises 4,25,000 shares to the Successful Resolution Applicant and promoters, 50,000 shares to Secured Financial Creditors, and 25,000 shares (5% stake) to existing public shareholders on a proportionate basis.

Original exchange filing (PDF)

More announcements from Devika Proteins Ltd

All Devika Proteins Ltd announcements